📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice. (2024)

First Author: Smith CW

Attributed to: How does inflammation regulate CLEC-2-mediated thrombosis after infection? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2024012713

PubMed Identifier: 38968150

Publication URI: http://europepmc.org/abstract/MED/38968150

Type: Journal Article/Review

Volume: 8

Parent Publication: Blood advances

Issue: 21

ISSN: 2473-9529